Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical business.
Related Posts
Copper Producer Aurubis Appoints New CEO After Metal Theft
Aurubis, one of the world’s largest copper producers, named a new chief executive in a sweeping restructuring of its executive board following cases of metal […]
Starliner Astronauts Say NASA Ran Short of Time to Test Boeing Craft
Sunita Williams and Barry Wilmore said they had input into the decision to extend their stay in space to eight months following the Starliner’s technical […]
Elon Musk Jabs at Billionaire Rival Jeff Bezos Over Trump
The world’s two richest men got into it on Musk’s social-media platform X over the election.